Real-world evidence and claims data compare amyloidosis therapies, linking outcomes and symptom burden to total cost of care. In ‘Applying Value-Based Frameworks in ATTR-CM Management,’ our experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results